Expression of SALL4 stemness marker in laryngeal squamous cell carcinomas (LSCCs) and its clinical significance

References

• Amabile G, et al. 2015. Dissecting the role of aberrant DNA methylation in human leukaemia. Nat Commun. 6:7091. [PubMed: 25997600] Tatetsu et al. Page 11 Gene. Author manuscript; available in PMC 2017 June 15.]
   PubMed Web of Science ®Google Scholar
• Baccelli I, Stenzinger A, Vogel V, Pfitzner BM, Klein C, Wallwiener M, Scharpff M, Saini M, Holland–Letz T, Sinn HP, et al. 2014. Co–expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patients. Oncotarget. 5:8147–8160.
   PubMedGoogle Scholar
• Barbato L, Bocchetti M, Di Biase A, Regad T. 2019 Aug 18. Cancer stem cells and targeting strategies cells. 8(8):926. doi:10.3390/cells808092.
   Google Scholar
• Baumann M, Krause M. 2010. CD44: a cancer stem cell-related biomarker with predictive potential for radiotherapy. Clin Cancer Res. 16(21):5091–5093.
   Web of Science ®Google Scholar
• Böhm J, Sustmann C, Wilhelm C, Kohlhase J. 2006 Sep 29. SALL4 is directly activated by TCF/LEF in the canonical Wnt signaling pathway. Biochem Biophys Res Commun. 348(3):898–907. doi:10.1016/j.bbrc.2006.07.124. Epub 2006 Jul 31. PMID: 16899215.
   PubMed Web of Science ®Google Scholar
• Brown R L, Reinke L M, Damerow M S, Perez D, Chodosh L A, Yang J, Cheng C. 2011. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest. 121:1064–1074.
   Web of Science ®Google Scholar
• Chai L, Liu H, Zhang Z, Wang F, Wang Q, Zhou S, Wang S. 2014. CD44 expression is predictive of poor prognosis in pharyngolaryngeal cancer: systematic review and meta-analysis. Tohoku J Exp Med. 232:9–19.
   Web of Science ®Google Scholar
• Cheng J, Deng R, Zhang P, Wu C, Wu K, Shi L, Liu X, Bai J, Deng M, Shuai X, et al. 2015. miR-219-5p plays a tumor suppressive role in colon cancer by targeting oncogene Sall4. Oncol Rep. 34(4):1923–1932.
   Web of Science ®Google Scholar
• Cheng J, Gao J, Shuai X, Tao K. 2016. Oncogenic protein SALL4 and ZNF217 as prognostic indicators in solid cancers: a meta analysis of individual studies. Oncotarget. 7:24314–24325. doi:10.18632/oncotarget.8237.
   PubMedGoogle Scholar
• Dawood S, Austin L, Cristofanilli M. 2014 Dec. Cancer stem cells: implications for cancer therapy. Oncology (Williston Park). 28(12):1101–1107, 1110.
   PubMed Web of Science ®Google Scholar
• de Jong MC, Pramana J, van der Wal JE, et al. 2010. CD44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin Cancer Res. 16:5329–5338R.
   PubMed Web of Science ®Google Scholar
• Di C, Sun J, Zhang H, Zhou P, Kong J. 1 Mar. 2018. High expression of SALL4 is associated with poor prognosis in squamous cell carcinoma of the uterine cervix. Int J Clin Exp Pathol. 11(3):1391–1398.
   PubMed Web of Science ®Google Scholar
• Du W, Ni L, Liu B, Wei Y, Lv Y, Qiang S, Dong J, Liu X. 2018 Apr 25. Upregulation of SALL4 by EGFR activation regulates the stemness of CD44-positive lung cancer. Oncogenesis. 7(4):36. doi:10.1038/s41389-018-0045-7. PMID: 29691367; PMCID: PMC5915399.
   PubMedGoogle Scholar
• Fu Z, Li G, Li Z, Wang Y, Zhao Y, Zheng S, Ye H, Luo Y, Zhao X, Wei L, et al. 2017 May 29. Endogenous miRNA sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells. Cell Death Discov. 3:17004. doi:10.1038/cddiscovery.2017.4. PMID: 28580169; PMCID: PMC5447127.
   Web of Science ®Google Scholar
• Fujii Y, et al. 2012. CDX1 confers intestinal phenotype on gastric epithelial cells via induction of stemnessassociated reprogramming factors SALL4 and KLF5. Proc Natl Acad Sci U S A. 109:20584–20589. PubMed: 23112162].
   PubMed Web of Science ®Google Scholar
• Gao L, Yan L, Lin B, Gao J, Liang X, Wang Y, et al. 2011. Enhancive effects of Lewis y antigen on CD44-mediated adhesion and spreading of human ovarian cancer cell line RMG-I. J Exp Clin Cancer Res. 30:15.
   Web of Science ®Google Scholar
• Gao S, Wang P, Hua Y, Xi H, Meng Z, Liu T, Chen Z, Liu L. 2016. ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer. Oncotarget. 7:1608–1618. https://www.oncotarget.com/article/6450/text/.
   Google Scholar
• Greco A, Rizzo M, De Virgilio A, Gallo A, Fusconi M, Pagliuca G, Martellucci S, Turchetta R, De Vincentiis M. 2016. Cancer stem cells in laryngeal cancer: what we know. Eur ArchOto-Rhino-Laryngol. 273:3487–3495.
   Web of Science ®Google Scholar
• Hao L, Yan Zhao Y, Wang Z, et al. 2016. Expression and clinical significance of SALL4 and b-catenin in colorectal cancer. J Mol Hist. 47:117–128. doi:10.1007/s10735-016-9656-5.
   PubMed Web of Science ®Google Scholar
• He J, Zhang W, Zhou Q, Zhao T, Song Y. 2013. Chai l and Li Y: Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4. Int J Biochem Cell Biol. 45:1962–1973.
   PubMed Web of Science ®Google Scholar
• He J, Zhou M, Chen X, Yue D, Yang L, Qin G, Zhang Z, Gao Q, Wang D, Zhang C, et al. 2016 Jun 21. Zhang y inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/beta-catenin pathway in esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 35(1):98. doi:10.1186/s13046-016-0378-z.
   PubMedGoogle Scholar
• Hou P, Zhao Y, Li Z, et al. 2014. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis. 5:e1287. doi:10.1038/cddis.2014.249.
   PubMed Web of Science ®Google Scholar
• Janisiewicz AM, Shin JH, Murillo-Sauca O, Kwok S, Le Q-T, Sunwoo JB. 2012. CD44(+) cells have cancer stem cell-like properties in nasopharyngeal carcinoma. Int Forum Allergy Rhinol. Nov. 2(6):465–470. doi:10.1002/alr.21068. Epub 2012 Aug 7.
   Web of Science ®Google Scholar
• Kokko LL, Hurme S, Maula SM, Alanen K, Grénman R, Kinnunen I, Ventelä S. 2011. Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma. Oral Oncol. 47(6): 510–516.
   PubMed Web of Science ®Google Scholar
• Kwong LN, Dove WF. 2009. APC and its modifiers in colon cancer. Adv Exp Med Biol. 14:85–106.
   Google Scholar
• Li A, et al. 2015. SALL4 is a new target in endometrial cancer. Oncogene. 34:63–72. PubMed: 24336327].
   PubMed Web of Science ®Google Scholar
• Lim CY, et al. 2008. Sall4 regulates distinct transcription circuitries in different blastocyst-derived stem cell lineages. Cell Stem Cell. 3:543–554. PubMed: 18804426].
   PubMed Web of Science ®Google Scholar
• Lin J, et al. 2013. Aberrant hypomethylation of SALL4 gene in patients with myelodysplastic syndrome. Leuk Res. 37:71–75. PubMed: 23122807].
   Web of Science ®Google Scholar
• Liu L, Zhang J, Yang X, Fang C, Xu H, Xi X. 2015. SALL4 as an epithelial-mesenchymal transition and drug resistance inducer through the regulation of c-Myc in endometrial cancer. PLoS One. 10(9):e0138515. Published 2015 Sep 25. doi:10.1371/journal.pone.0138515.
   PubMed Web of Science ®Google Scholar
• Ma Z, Wang YY, Xin HW, Wang L, Arfuso F, Dharmarajan A, Kumar AP, Wang H, Tang FR, Warrier S, et al. 2019 Mar. The expanding roles of long non-coding RNAs in the regulation of cancer stem cells. Int J Biochem Cell Biol. 108:17–20. doi:10.1016/j.biocel.2019.01.003. Epub 2019 Jan 7. PMID: 30630112.
   Web of Science ®Google Scholar
• Masuko K, Okazaki S, Satoh M, Tanaka G, Ikeda T, Torii R, Ueda E, Nakano T, Danbayashi M, Tsuruoka T, et al. 2012. Anti-tumor effect against human cancer xenografts by a fully human monoclonal antibody to a variant 8-epitope of CD44R1 expressed on cancer stem cells. PLoS ONE. 7(1):e29728.
   Web of Science ®Google Scholar
• Mei K, et al. 2009. Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases. Mod Pathol. 22:1628–1636. PubMed: 19820689].
   PubMed Web of Science ®Google Scholar
• Mima K, Hayashi H, Imai K, Kuroki H, Nakagawa S, Okabe H, Chikamoto A, Watanabe M, Beppu T, Baba H. 2013. High CD44s expression is associated with the EMT expression profile and intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy. J Hepatobiliary Pancreat Sci. 20:429–434.
   PubMed Web of Science ®Google Scholar
• Nastaly P, et al. 2014. Circulating tumor cells in patients with testicular germ cell tumors. Clin Cancer Res. 20:3830–3841. PubMed: 24634372].
   Web of Science ®Google Scholar
• Nicolè L, Sanavia T, Veronese N, Cappellesso R, Luchini C, Dabrilli P, Fassina A. 2017 Apr 4. Oncofetal gene SALL4 and prognosis in cancer: A systematic review with meta-analysis. Oncotarget. 8(14):22968–22979. doi:10.18632/oncotarget.14952. PMID: 28160555; PMCID: PMC5410278.
   PubMedGoogle Scholar
• Nie X, Guo E, Wu C. 2019 Apr. SALL4 induces Radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway. Cancer Med. 8(4):1779–1792. doi:10.1002/cam4.2056. Epub 2019 Mar 24.
   PubMed Web of Science ®Google Scholar
• Nishino K, et al. 2010. Defining hypo-methylated regions of stem cell-specific promoters in human iPS cells derived from extra-embryonic amnions and lung fibroblasts. PLoS One. 5:e13017. PubMed: 20885964].
   Web of Science ®Google Scholar
• Ouban A, Ahmed A. 2015 Jul. Analysis of the distribution and expression of claudin-1 tight junction protein in the oral cavity. Appl Immunohistochem Mol Morphol. 23(6):444–448. doi:10.1097/PAI.0000000000000104.
   Google Scholar
• Pan L, Liang W, Gu J, Zang X, Huang Z, Shi H, Chen J, Fu M, Zhang P, Xiao X, et al. 2017 Dec 6. Long noncoding RNA DANCR is activated by SALL4 and promotes the proliferation and invasion of gastric cancer cells. Oncotarget. 9(2):1915–1930. doi:10.18632/oncotarget.23019. PMID: 29416741; PMCID: PMC5788609.
   Google Scholar
• Qi F, Liu X, Wu H, Yu X, Wei C, Huang X, Ji G, Nie F, Wang K. 2017. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer. J Hematol Oncol. 10:48.
   PubMed Web of Science ®Google Scholar
• Shen H, Li L, Wang D, Yang S, Chen X, Zhou S, Zhong S, Zhao J, Tang J. 2017 Jul 4. Higher expression of SALL4 predicts poor cancer prognosis: a meta-analysis. Cancer Biomark. 19(4):365–373. doi:10.3233/CBM-160052.
   PubMed Web of Science ®Google Scholar
• Shen Z, Li Q, Deng H, Lu D, Song H, Guo J. 2014 Sep 22. Long non-coding RNA profiling in laryngeal squamous cell carcinoma and its clinical significance: potential biomarkers for LSCC. PLoS One. 9(9):e108237. doi:10.1371/journal.pone.0108237. eCollection 2014.
   PubMed Web of Science ®Google Scholar
• Si X, Zang R, Zhang E, Liu Y, Shi X, Zhang E, Shao L, Li A, Yang N, Han X, et al. 2016. LncRNA H19 confers chemoresistance in ERalpha-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK. Oncotarget. 7:81452–81462. doi:10.18632/oncotarget.13263.
   PubMed Web of Science ®Google Scholar
• Tatetsu H, Kong NR, Chong G, et al. 2016 Jun 15. SALL4, the missing link between stem cells, development and cancer. J. 584(2):111–119. doi:10.1016/j.gene.2016.02.019. Epub 2016 Feb 16.
   Google Scholar
• Ueno S, et al. 2014. Aberrant expression of SALL4 in acute B cell lymphoblastic leukemia: mechanism, function, and implication for a potential novel therapeutic target. Exp Hematol. 42:307–316. e308. [PubMed: 24463278].
   Web of Science ®Google Scholar
• Wang F, et al. 2013. Stem cell factor SALL4, a potential prognostic marker for myelodysplastic syndromes. J Hematol Oncol. 6:73. PubMed: 24283704].
   PubMed Web of Science ®Google Scholar
• Wu H, Liu C, Fan X, et al. 2017 Aug 23. Spalt-like Transcription Factor 4 as a potential diagnostic and prognostic marker of colorectal cancer. Cancer Biomark. 20(2):191–198. doi:10.3233/CBM-170204.
   Web of Science ®Google Scholar
• Yang J, et al. 2008. Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murineembryonic stem cells. Proc Natl Acad Sci U S A. 105:19756–19761. PubMed: 19060217].
   PubMed Web of Science ®Google Scholar
• Yang J, Corsello TR, Ma Y. 2012. Stem cell gene SALL4 suppresses transcription through recruitment of DNA methyltransferases. J Biol Chem. 287:1996–2005. PubMed: 22128185].
   PubMed Web of Science ®Google Scholar
• Yong KJ, Gao C, Lim JS, Yan B, Yang H, Dimitrov T, Kawasaki A, Ong CW, Wong KF, Lee S, et al. 2013 Jun 13. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med. 368(24):2266–2276. doi:10.1056/NEJMoa1300297.
   PubMed Web of Science ®Google Scholar
• Yu D, Jin C, Liu Y, Yang J, Zhao Y, Wang H, Zhao X, Cheng J, Liu X, Liu C. 2013 Dec. Tumour clinical implications of cancer stem cell-like side population cells in human laryngeal cancer. Biol. 34(6):3603–3610. doi:10.1007/s13277-013-0941-6. Epub 2013 Jun 27.
   Google Scholar
• Yu D, Jin C, Liu Y, Yang J, Zhao Y, Wang H, Zhao X, Cheng J, Liu X, Liu C. 2013. Clinical implications of cancer stem cell-like side population cells in human laryngeal cancer. Tumour Biol. 34(6):3603–3610.
   Google Scholar
• Yuan JH, Li WX, Hu C, Zhang B. 2020 Jul. Upregulation of SNHG12 accelerates cell proliferation, migration, invasion and restrain cell apoptosis in breast cancer by enhancing regulating SALL4 expression via sponging miR-15a-5p. Neoplasma. 67(4):861–870. doi:10.4149/neo_2020_190808N731. Epub 2020 May 6. PMID: 32386479.
   PubMed Web of Science ®Google Scholar
• Yuan X, Zhang X X, Zhang W, Liang W, Zhang P, Shi H, Zhang B, Shao M, Yan Y, Qian H, Xu W. 2016. SALL4 promotes gastric cancer progression through activating CD44 expression. Oncogenesis. 5:e268. doi:10.1038/oncsis.2016.69.
   PubMed Web of Science ®Google Scholar
• Zhang J, et al. 2006. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol. 8:1114–1123. PubMed: 16980957].
   PubMed Web of Science ®Google Scholar
• Zhang L, et al. 2014. SALL4, a novel marker for human gastric carcinogenesis and metastasis. Oncogene. 33:5491–5500. PubMed: 24276240].
   PubMed Web of Science ®Google Scholar
• Zhang X, Yuan X, Zhu W, Qian H, Xu W. 2015. SALL4: an emerging cancer biomarker and target. Cancer Lett. 357:55–62.
   PubMed Web of Science ®Google Scholar